Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate.
Karpenko LI, Rudometov AP, Sharabrin SV, Shcherbakov DN, Borgoyakova MB, Bazhan SI, Volosnikova EA, Rudometova NB, Orlova LA, Pyshnaya IA, Zaitsev BN, Volkova NV, Azaev MS, Zaykovskaya AV, Pyankov OV, Ilyichev AA. Karpenko LI, et al. Among authors: borgoyakova mb. Vaccines (Basel). 2021 Jan 21;9(2):76. doi: 10.3390/vaccines9020076. Vaccines (Basel). 2021. PMID: 33494530 Free PMC article.
Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens.
Starostina EV, Sharabrin SV, Antropov DN, Stepanov GA, Shevelev GY, Lemza AE, Rudometov AP, Borgoyakova MB, Rudometova NB, Marchenko VY, Danilchenko NV, Chikaev AN, Bazhan SI, Ilyichev AA, Karpenko LI. Starostina EV, et al. Among authors: borgoyakova mb. Vaccines (Basel). 2021 May 3;9(5):452. doi: 10.3390/vaccines9050452. Vaccines (Basel). 2021. PMID: 34063689 Free PMC article.
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems.
Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Shanshin DV, Rudometov AP, Karpenko LI, Belenkaya SV, Isaeva AA, Nesmeyanova VS, Kazachinskaia EI, Volosnikova EA, Esina TI, Zaykovskaya AV, Pyankov OV, Borisevich SS, Shelemba AA, Chikaev AN, Ilyichev AA. Merkuleva IA, et al. Among authors: borgoyakova mb. Vaccines (Basel). 2022 Jan 9;10(1):96. doi: 10.3390/vaccines10010096. Vaccines (Basel). 2022. PMID: 35062757 Free PMC article.
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice.
Borgoyakova MB, Karpenko LI, Rudometov AP, Volosnikova EA, Merkuleva IA, Starostina EV, Zadorozhny AM, Isaeva AA, Nesmeyanova VS, Shanshin DV, Baranov KO, Volkova NV, Zaitsev BN, Orlova LA, Zaykovskaya AV, Pyankov OV, Danilenko ED, Bazhan SI, Shcherbakov DN, Taranin AV, Ilyichev AA. Borgoyakova MB, et al. Int J Mol Sci. 2022 Feb 16;23(4):2188. doi: 10.3390/ijms23042188. Int J Mol Sci. 2022. PMID: 35216301 Free PMC article.
[Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein].
Borgoyakova MB, Karpenko LI, Rudometov AP, Shanshin DV, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Murashkin DE, Shcherbakov DN, Volosnikova EA, Starostina EV, Orlova LA, Danilchenko NV, Zaikovskaya AV, Pyankov OV, Ilyichev AA. Borgoyakova MB, et al. Mol Biol (Mosk). 2021 Nov-Dec;55(6):987-998. doi: 10.31857/S0026898421060045. Mol Biol (Mosk). 2021. PMID: 34837703 Free article. Russian.
Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
Borgoyakova MB, Karpenko LI, Rudometov AP, Shanshin DV, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Murashkin DE, Shcherbakov DN, Volosnikova EA, Starostina EV, Orlova LA, Danilchenko NV, Zaikovskaya AV, Pyankov OV, Ilyichev AA. Borgoyakova MB, et al. Mol Biol. 2021;55(6):889-898. doi: 10.1134/S0026893321050046. Epub 2021 Dec 17. Mol Biol. 2021. PMID: 34955558 Free PMC article.
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, Aripov VS, Shanshin DV, Karpenko LI, Belenkaya SV, Kazachinskaia EI, Volosnikova EA, Esina TI, Sergeev AA, Titova KA, Konyakhina YV, Zaykovskaya AV, Pyankov OV, Kolosova EA, Viktorina OE, Shelemba AA, Rudometov AP, Ilyichev AA. Merkuleva IA, et al. Among authors: borgoyakova mb. Viruses. 2022 May 16;14(5):1060. doi: 10.3390/v14051060. Viruses. 2022. PMID: 35632800 Free PMC article.
Enhancing the Immunogenicity of Vaccinia Virus.
Shchelkunov SN, Yakubitskiy SN, Sergeev AA, Starostina EV, Titova KA, Pyankov SA, Shchelkunova GA, Borgoyakova MB, Zadorozhny AM, Orlova LA, Kisakov DN, Karpenko LI. Shchelkunov SN, et al. Among authors: borgoyakova mb. Viruses. 2022 Jun 30;14(7):1453. doi: 10.3390/v14071453. Viruses. 2022. PMID: 35891430 Free PMC article.
Immunogenic and Protective Properties of Recombinant Hemagglutinin of Influenza A (H5N8) Virus.
Rudometova NB, Fando AA, Kisakova LA, Kisakov DN, Borgoyakova MB, Litvinova VR, Yakovlev VA, Tigeeva EV, Vahitov DI, Sharabrin SV, Shcherbakov DN, Evseenko VI, Ivanova KI, Gudymo AS, Ilyicheva TN, Marchenko VY, Ilyichev AA, Rudometov AP, Karpenko LI. Rudometova NB, et al. Among authors: borgoyakova mb. Vaccines (Basel). 2024 Jan 29;12(2):143. doi: 10.3390/vaccines12020143. Vaccines (Basel). 2024. PMID: 38400127 Free PMC article.
17 results